1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior ImmunotherapyAdvanced Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingPhase 22026-05-26NCT05585580